I'm very happy that dossiers are being submitted, there will be a time when 2-3 products are launched a year, making ACR a self propelled money maker......by the time 6 dossiers are making money..... there should be that many again that have been submitted waiting FDA approval. And IF we are cashflow positive by the end of this calendar year that's a huge milestone. No matter what we all think...... we cant fault ACR for not sticking to their plan. Must be at least 7, maybe 8 years so far. Jet
- Forums
- ASX - By Stock
- ACR
- News: ACR Acrux Says Its Sixth Generic Application Accepted By U.S. FDA For Review
ACR
acrux limited
Add to My Watchlist
5.00%
!
1.9¢

News: ACR Acrux Says Its Sixth Generic Application Accepted By U.S. FDA For Review, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $8.155M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $12.39K | 620.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 421000 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 286349 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 425000 | 0.019 |
3 | 381800 | 0.018 |
3 | 472000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 286349 | 2 |
0.021 | 80630 | 1 |
0.022 | 204574 | 4 |
0.023 | 115126 | 4 |
0.024 | 306848 | 8 |
Last trade - 11.30am 18/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online